date,銘柄名,コード,ニューインデックス区分,企業コード,年,指標名,スコア
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,クチコミ総合評価,2.45
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,クチコミ総合評価,2.51
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,クチコミ総合評価,2.51
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,クチコミ総合評価,2.56
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,クチコミ総合評価,2.6
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,クチコミ総合評価,2.61
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,クチコミ総合評価,2.67
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,クチコミ総合評価,2.83
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,クチコミ総合評価,2.71
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,クチコミ総合評価,2.64
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,待遇面の満足度,2.68
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,待遇面の満足度,2.75
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,待遇面の満足度,2.74
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,待遇面の満足度,2.65
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,待遇面の満足度,2.59
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,待遇面の満足度,2.65
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,待遇面の満足度,2.57
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,待遇面の満足度,2.52
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,待遇面の満足度,2.4
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,待遇面の満足度,2.4
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,社員の士気,2.26
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,社員の士気,2.32
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,社員の士気,2.31
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,社員の士気,2.39
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,社員の士気,2.49
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,社員の士気,2.48
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,社員の士気,2.52
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,社員の士気,2.59
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,社員の士気,2.5
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,社員の士気,2.2
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,風通しの良さ,2.51
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,風通しの良さ,2.52
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,風通しの良さ,2.53
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,風通しの良さ,2.62
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,風通しの良さ,2.64
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,風通しの良さ,2.72
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,風通しの良さ,2.81
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,風通しの良さ,2.83
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,風通しの良さ,2.95
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,風通しの良さ,2.8
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,社員の相互尊重,3.02
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,社員の相互尊重,3.15
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,社員の相互尊重,3.19
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,社員の相互尊重,3.21
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,社員の相互尊重,3.28
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,社員の相互尊重,3.24
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,社員の相互尊重,3.41
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,社員の相互尊重,3.74
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,社員の相互尊重,3.29
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,社員の相互尊重,2.8
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,20代成長環境,2.66
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,20代成長環境,2.67
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,20代成長環境,2.66
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,20代成長環境,2.67
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,20代成長環境,2.67
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,20代成長環境,2.63
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,20代成長環境,2.74
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,20代成長環境,2.9
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,20代成長環境,2.85
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,20代成長環境,3.38
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,人材の長期育成,1.95
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,人材の長期育成,1.99
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,人材の長期育成,1.97
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,人材の長期育成,2.04
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,人材の長期育成,2.12
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,人材の長期育成,2.09
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,人材の長期育成,2.21
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,人材の長期育成,2.38
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,人材の長期育成,2.4
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,人材の長期育成,2.6
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,法令順守意識,2.07
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,法令順守意識,2.16
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,法令順守意識,2.19
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,法令順守意識,2.34
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,法令順守意識,2.47
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,法令順守意識,2.55
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,法令順守意識,2.57
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,法令順守意識,2.79
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,法令順守意識,2.7
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,法令順守意識,2
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,人事評価の適正感,2.44
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,人事評価の適正感,2.45
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,人事評価の適正感,2.4
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,人事評価の適正感,2.43
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,人事評価の適正感,2.4
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,人事評価の適正感,2.43
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,人事評価の適正感,2.38
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,人事評価の適正感,2.62
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,人事評価の適正感,2.45
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,人事評価の適正感,2.8
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,有給休暇消化率,33.66
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,有給休暇消化率,36.72
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,有給休暇消化率,39.48
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,有給休暇消化率,48.58
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,有給休暇消化率,54.28
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,有給休暇消化率,57.92
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,有給休暇消化率,57.26
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,有給休暇消化率,56.72
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,有給休暇消化率,60.25
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,有給休暇消化率,57
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2016,残業時間(月間),29.65
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2017,残業時間(月間),27.17
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2018,残業時間(月間),24.88
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2019,残業時間(月間),21.33
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2020,残業時間(月間),20.29
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2021,残業時間(月間),19.29
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2022,残業時間(月間),17.88
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2023,残業時間(月間),21.66
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2024,残業時間(月間),19.15
2025/6/30,科研製薬,4521,TOPIX Mid400,a0910000000Fr3J,2025,残業時間(月間),7.6
